- Home
- CODA vs ASRT Comparison
CODA vs ASRT Comparison
Compare CODA & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- ASRT
- Stock Information
- Founded
- CODA 1994
- ASRT 1995
- Country
- CODA United States
- ASRT United States
- Employees
- CODA N/A
- ASRT N/A
- Industry
- CODA Industrial Machinery/Components
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- ASRT Health Care
- Exchange
- CODA Nasdaq
- ASRT Nasdaq
- Market Cap
- CODA 88.8M
- ASRT 83.2M
- IPO Year
- CODA N/A
- ASRT 1997
- Fundamental
- Price
- CODA $7.97
- ASRT $0.73
- Analyst Decision
- CODA
- ASRT Strong Buy
- Analyst Count
- CODA 0
- ASRT 1
- Target Price
- CODA N/A
- ASRT $3.00
- AVG Volume (30 Days)
- CODA 73.5K
- ASRT 687.8K
- Earning Date
- CODA 09-15-2025
- ASRT 11-10-2025
- Dividend Yield
- CODA N/A
- ASRT N/A
- EPS Growth
- CODA 15.09
- ASRT N/A
- EPS
- CODA 0.30
- ASRT N/A
- Revenue
- CODA $24,347,217.00
- ASRT $137,354,000.00
- Revenue This Year
- CODA $30.82
- ASRT N/A
- Revenue Next Year
- CODA $20.84
- ASRT $4.10
- P/E Ratio
- CODA $27.13
- ASRT N/A
- Revenue Growth
- CODA 29.34
- ASRT 9.22
- 52 Week Low
- CODA $5.76
- ASRT $0.51
- 52 Week High
- CODA $10.54
- ASRT $1.08
- Technical
- Relative Strength Index (RSI)
- CODA 39.59
- ASRT 40.41
- Support Level
- CODA $7.80
- ASRT $0.73
- Resistance Level
- CODA $8.39
- ASRT $0.79
- Average True Range (ATR)
- CODA 0.43
- ASRT 0.06
- MACD
- CODA -0.14
- ASRT -0.01
- Stochastic Oscillator
- CODA 17.71
- ASRT 9.63
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.